Partenaires

IBCP
CNRS UCBL

Logo unite LBTI


Rechercher

Sur ce site

Sur le Web du CNRS


Accueil du site > Pôle Rockefeller > Publications

Publications

[2016] [2015] [2012] [2008] [2007] [2006] [1997

2016 [Top] 4
20.  Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles.   
Boisgard AS, Lamrayah M, Dzikowski M, Salmon D, Kirilov P, Primard C, Pirot F, Fromy B, Verrier B
(2016) Eur J Pharm Biopharm 

19.  Cell surface glycans in the human stratum corneum: distributionand depth-related changes.   
Abdayem R, Formanek F, Minondo AM, Potter A, Haftek M
(2016) Exp Dermatol 25 : 865-871

18.  Fragility of epidermis in newborns, children and adolescents.   
Blume-Peytavi U, Tan J, Tennstedt D, Boralevi F, Fabbrocini G, Torrelo A, Soares-Oliveira R, Haftek M, Rossi AB, Thouvenin MD, Mangold J, Galliano MF, Hernandez-Pigeon H, Aries MF, Rouvrais C, Bessou-Touya S, Duplan H, Castex-Rizzi N, Mengeaud V, Ferret PJ, Clouet E, Saint Aroman M, Carrasco C, Coutanceau C, Guiraud B, Boyal S, Herman A, Delga H, Biniek K, Dauskardt R
(2016) J Eur Acad Dermatol Venereol 30 Suppl 4 : 3-56

17.  Percutaneous absorption of benzophenone-3 loaded lipid nanoparticles and polymeric nanocapsules: A comparative study.   
Gilbert E, Roussel L, Serre C, Sandouk R, Salmon D, Kirilov P, Haftek M, Falson F, Pirot F
(2016) Int J Pharm 504 : 48-58

2015 [Top] 7
16.  Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis.   
Riethmuller C, McAleer MA, Koppes SA, Abdayem R, Franz J, Haftek M, Campbell LE, MacCallum SF, McLean WH, Irvine AD, Kezic S
(2015) J Allergy Clin Immunol 136 : 1573-1580

15.  [Aseptic process validation and stability study of an injectable preparation of fructose (5%)-glycerol (10%) as part of a hospital clinical research program on endoscopic curative treatment for early epithelial neoplastic lesions of the gastrointestinal tract].   
Tall ML, Salmon D, Diouf E, Drai J, Filali S, Lepilliez V, Pioche M, Laleye D, Dhelens C, Ponchon T, Pivot C, Pirot F
(2015) Ann Pharm Fr 73 : 139-49

14.  New easy handling and sampling device for bioavailability screening of topical formulations.   
Salmon D, Gilbert E, Gioia B, Haftek M, Pivot C, Verrier B, Pirot F
(2015) Eur J Dermatol 25 Suppl 1 : 23-9

13.  Measurement, analysis and prediction of topical UV filter bioavailability.   
Roussel L, Gilbert E, Salmon D, Serre C, Gabard B, Haftek M, Maibach HI, Pirot F
(2015) Int J Pharm 478 : 804-10

12.  [Injectable preparation of labeled leucine with the carbon 13 for a clinical research program on the Alzheimer disease: pharmaceutical control of raw materials and the finished product and stability study].   
Tall ML, Lehmann S, Diouf E, Gerard C, Filali S, Gabelle A, Hirtz C, Gabert L, Sauvinet V, Pirot F, Pivot C
(2015) Ann Pharm Fr 73 : 43-59

11.  Deleterious effects of skin freezing contribute to variable outcomes of the predictive drug permeation studies using hydrophilic molecules.   
Abdayem R, Roussel L, Zaman N, Pirot F, Gilbert E, Haftek M
(2015) Exp Dermatol 24 : 972-4

10.  Modulation of transepithelial electric resistance (TEER) in reconstructed human epidermis by excipients known to permeate intestinal tight junctions.   
Abdayem R, Callejon S, Portes P, Kirilov P, Demarne F, Pirot F, Jannin V, Haftek M
(2015) Exp Dermatol 24 : 686-91

2012 [Top] 5
9.  Preparation and evaluation of nanoparticles for directed tissue engineering.   
Hansson A, Di Francesco T, Falson F, Rousselle P, Jordan O, Borchard G
(2012) Int J Pharm 439 : 73-80

8.  Influence of the mesenchymal cell source on oral epithelial development.   
Kinikoglu B, Rovere MR, Haftek M, Hasirci V, Damour O
(2012) J Tissue Eng Regen Med 6 : 245-52

7.  A synthetic peptide derived from the parasite Toxoplasma gondii triggers human dendritic cells' migration.   
Persat F, Mercier C, Ficheux D, Colomb E, Trouillet S, Bendridi N, Musset K, Loeuillet C, Cesbron-Delauw MF, Vincent C
(2012) J Leukoc Biol 92 : 1241-50

6.  In vitro evaluation of an RGD-functionalized chitosan derivative for enhanced cell adhesion.   
Hansson A, Hashom N, Falson F, Rousselle P, Jordan O, Borchard G
(2012) Carbohydr Polym 90 : 1494-500

5.  Functional interplay between p63 and p53 controls RUNX1 function in the transition from proliferation to differentiation in human keratinocytes.   
Masse I, Barbollat-Boutrand L, Molina M, Berthier-Vergnes O, Joly-Tonetti N, Martin MT, Caron De Fromentel C, Kanitakis J, Lamartine J
(2012) Cell Death Dis 3 : e318-e318

2008 [Top] 1
4.  Expression of estrogen-related receptor gamma (ERRgamma) in human skin.     
Krahn-Bertil E, Bolzinger MA, Andre V, Orly I, Kanitakis J, Rousselle P, Damour O
(2008) Eur J Dermatol 18 : 427-32

2007 [Top] 1
3.  [Hand allografts: experience from Lyon team].   
Gazarian A, Abrahamyan DO, Petruzzo P, Kanitakis J, Guigal V, Garret J, Rizzo C, Durand PY, Fredenucci JF, Streichenberger T, Parmentier H, Galewicz T, Guillot M, Sirigu A, Burloux G, Morelon E, Braye F, Badet L, Martin X, Dubernard JM, Eljaafari A
(2007) Ann Chir Plast Esthet 52 : 424-35

2006 [Top] 1
2.  The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model.     
Bouez C, Reynaud C, Noblesse E, Thepot A, Gleyzal C, Kanitakis J, Perrier E, Damour O, Sommer P
(2006) Clin Cancer Res 12 : 1463-9

1997 [Top] 1
1.  Hyperphosphorylation of beta-catenin on serine-threonine residues and loss of cell-cell contacts induced by calyculin A and okadaic acid in human epidermal cells.     
Serres M, Grangeasse C, Haftek M, Durocher Y, Duclos B, Schmitt D
(1997) Exp Cell Res 231 : 163-72